These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29160103)

  • 1. Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.
    Biasco L
    Hum Gene Ther; 2017 Dec; 28(12):1122-1129. PubMed ID: 29160103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vectors: post entry events and genomic alterations.
    Nowrouzi A; Glimm H; von Kalle C; Schmidt M
    Viruses; 2011 May; 3(5):429-55. PubMed ID: 21994741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of retroviral integration and mutagenesis.
    Cavazza A; Moiani A; Mavilio F
    Hum Gene Ther; 2013 Feb; 24(2):119-31. PubMed ID: 23330935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis.
    Biasco L; Rothe M; Schott JW; Schambach A
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):737-752. PubMed ID: 28895844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].
    Doi K; Takeuchi Y
    Uirusu; 2015; 65(1):27-36. PubMed ID: 26923955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones.
    Bushman FD
    Mol Ther; 2020 Feb; 28(2):352-356. PubMed ID: 31951833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
    Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
    Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.
    Wang GP; Berry CC; Malani N; Leboulch P; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Bushman FD
    Blood; 2010 Jun; 115(22):4356-66. PubMed ID: 20228274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The yin and yang of stem cell gene therapy: insights into hematopoiesis, leukemogenesis, and gene therapy safety.
    Dunbar CE
    Hematology Am Soc Hematol Educ Program; 2007; ():460-5. PubMed ID: 18024665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances in retroviral gene therapy.
    Yi Y; Noh MJ; Lee KH
    Curr Gene Ther; 2011 Jun; 11(3):218-28. PubMed ID: 21453283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-induced oncogenesis and safety of retroviral vectors.
    Nair V
    Curr Opin Mol Ther; 2008 Oct; 10(5):431-8. PubMed ID: 18830918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity of retroviral hematopoietic stem cell gene therapy.
    Trobridge GD
    Expert Opin Biol Ther; 2011 May; 11(5):581-93. PubMed ID: 21375467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral vectors for gene therapy.
    Maier P; von Kalle C; Laufs S
    Future Microbiol; 2010 Oct; 5(10):1507-23. PubMed ID: 21073311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral integrations in gene therapy trials.
    Biasco L; Baricordi C; Aiuti A
    Mol Ther; 2012 Apr; 20(4):709-16. PubMed ID: 22252453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the genotoxic potential of retroviral vectors.
    Ramezani A; Hawley TS; Hawley RG
    Methods Mol Biol; 2008; 434():183-203. PubMed ID: 18470646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity assay for gene therapy vectors in tumor prone Cdkn2a⁻/⁻ mice.
    Montini E; Cesana D
    Methods Enzymol; 2012; 507():171-85. PubMed ID: 22365774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of retroviral vectors.
    Gabriel R; Schmidt M; von Kalle C
    Curr Opin Immunol; 2012 Oct; 24(5):592-7. PubMed ID: 22981243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integration of AAV vectors and insertional mutagenesis].
    Rossi A; Salvetti A
    Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput genomic mapping of vector integration sites in gene therapy studies.
    Beard BC; Adair JE; Trobridge GD; Kiem HP
    Methods Mol Biol; 2014; 1185():321-44. PubMed ID: 25062639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.